Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents — MYCOS

Systemic Fungal Infections Clinical Trial

Official title:
A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Status Completed

Clinical Trial Summary

This multicenter observational cohort study proposes to establish the risks of short and long-term outcomes in users of parenteral micafungin and in users of other parenteral antifungal agents from 2005 through 2012 with follow-up until 2017.

Clinical Trial Description

All eligible patients treated with a parenteral antifungal agent at any time during the years 2005-2012 in each of the participating hospitals, will be included in the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01686607
Study type	Observational
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase
Start date	October 1, 2012
Completion date	April 30, 2018

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02968134` - Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients	Phase 4
	Completed	`NCT00721578` - A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections	N/A